Free Trial

SNDL (SNDL) Competitors

SNDL logo
$2.53 +0.06 (+2.43%)
Closing price 04:00 PM Eastern
Extended Trading
$2.47 -0.06 (-2.37%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNDL vs. ACB, CGC, CRON, OGI, TLRY, AGIO, IDYA, DNLI, OCUL, and HRMY

Should you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), Agios Pharmaceuticals (AGIO), IDEAYA Biosciences (IDYA), Denali Therapeutics (DNLI), Ocular Therapeutix (OCUL), and Harmony Biosciences (HRMY). These companies are all part of the "pharmaceutical products" industry.

SNDL vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

Aurora Cannabis has a net margin of -5.66% compared to SNDL's net margin of -10.38%. Aurora Cannabis' return on equity of -1.49% beat SNDL's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-5.66% -1.49% -1.06%
SNDL -10.38%-8.58%-7.23%

Aurora Cannabis has a beta of 1.84, indicating that its share price is 84% more volatile than the S&P 500. Comparatively, SNDL has a beta of 3.57, indicating that its share price is 257% more volatile than the S&P 500.

SNDL has a consensus price target of $4.00, indicating a potential upside of 58.10%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.00
SNDL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aurora Cannabis has higher earnings, but lower revenue than SNDL. Aurora Cannabis is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.22$1.63M-$0.19-28.05
SNDL$671.81M0.99-$69.18M-$0.27-9.37

In the previous week, Aurora Cannabis and Aurora Cannabis both had 3 articles in the media. Aurora Cannabis' average media sentiment score of 1.19 beat SNDL's score of 0.41 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SNDL
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

47.6% of Aurora Cannabis shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Aurora Cannabis beats SNDL on 12 of the 16 factors compared between the two stocks.

Get SNDL News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDL vs. The Competition

MetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$664.83M$10.61B$5.74B$9.78B
Dividend YieldN/A1.86%4.40%4.04%
P/E Ratio-9.3721.2030.8326.39
Price / Sales0.9931.79382.9086.63
Price / CashN/A24.9137.7259.11
Price / Book0.853.5110.106.62
Net Income-$69.18M$210.11M$3.26B$265.42M
7 Day Performance14.48%5.86%3.90%3.58%
1 Month Performance67.00%11.12%3.73%0.46%
1 Year Performance29.08%-7.57%37.68%19.41%

SNDL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNDL
SNDL
1.8992 of 5 stars
$2.53
+2.4%
$4.00
+58.1%
+18.8%$664.83M$671.81M-9.372,516High Trading Volume
ACB
Aurora Cannabis
0.9411 of 5 stars
$5.12
+0.8%
N/A-18.2%$289.02M$246.72M-26.951,130Positive News
CGC
Canopy Growth
0.2734 of 5 stars
$1.37
+5.4%
N/A-76.2%$328.59M$225.65M-0.453,150High Trading Volume
CRON
Cronos Group
0.7908 of 5 stars
$2.53
+6.8%
N/A+10.9%$969.09M$117.61M50.60450Trending News
OGI
Organigram Global
0.3525 of 5 stars
$1.53
+7.0%
N/A-17.1%$205.07M$117.47M30.61860
TLRY
Tilray Brands
2.2222 of 5 stars
$1.14
+10.7%
$1.92
+68.1%
-22.0%$1.25B$821.31M-0.492,842Trending News
Analyst Forecast
Options Volume
AGIO
Agios Pharmaceuticals
4.3492 of 5 stars
$37.45
+1.2%
$56.33
+50.4%
-17.4%$2.18B$40.88M3.40390Positive News
IDYA
IDEAYA Biosciences
4.433 of 5 stars
$24.75
+1.7%
$48.09
+94.3%
-37.5%$2.17B$7M-6.5380News Coverage
DNLI
Denali Therapeutics
4.2983 of 5 stars
$14.82
+0.8%
$33.62
+126.8%
-39.3%$2.17B$330.53M-5.29430Positive News
OCUL
Ocular Therapeutix
3.961 of 5 stars
$12.31
-2.5%
$17.20
+39.7%
+36.7%$2.14B$63.72M-9.62230Positive News
HRMY
Harmony Biosciences
4.7144 of 5 stars
$36.41
-1.2%
$51.00
+40.1%
+2.8%$2.09B$714.73M11.75200Positive News

Related Companies and Tools


This page (NASDAQ:SNDL) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners